As a member of The Health Charities Coalition of Canada (HCCC) our organization, Osteoporosis Canada, is pleased to see federal support for the establishment of the Canadian Drug Agency which […]

Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada – Updated August 6, 2013 Calcitonin is a hormone found naturally in our bodies. A synthetic form […]

There are many questions for those taking osteoporosis medications and treatments including why they are being prescribed, concerns over side effects and the importance of sticking to a medication schedule. […]

SECONDARY OSTEOPOROSIS Medications and medical conditions can increase the risk of osteoporosis and osteoporotic fractures. Drugs and Diseases that can Cause Bone Loss, Falls and/or Fractures There are several well […]

Treatments Did you know? Osteoporosis leads to fragility fractures. These are broken bones that happen from a minor injury but that have major consequences such as pain, disability and sometimes […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]